Effects of A&F variants on monthly number of CNS-active medications prescribed
REGRESSION
Primary outcome analyses included the broader population of included physicians’ residents (i.e., not only those with a recent RAI assessment). The mean number of CNS-active medications prescribed per resident at the baseline month (December 1, 2016) and at the last follow-up time point (July 1, 2017) are displayed in Table CNS-active medications per resident at baseline and follow-upThe general linear mixed effects regression model indicated there were no significant deviations from the secular trend in the monthly mean number of CNS-active medications in any of the arms (Table Results of general linear mixed effects regression model predicting deviations from the secular trend in the monthly mean number of CNS-active medicationsMean number of CNS-active medications prescribed across trial arms at 6 months post-intervention: pairwise comparisons